# A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

> **NCT01969877** · PHASE3 · COMPLETED · sponsor: **Lund University Hospital** · enrollment: 298 (actual)

## Conditions studied

- Locally Advanced Head and Neck Cancer

## Interventions

- **DRUG:** cetuximab
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT01969877
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01969877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01969877, "A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01969877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*